Healio Gastroenterology presents the following reports on the most recent research on inflammatory bowel disease.
These reports include new research on the impact of non-alcoholic fatty liver disease and diet, as well as news on the COVID-19 vaccine.
Patients with inflammatory bowel disease who also had non-alcoholic fatty liver disease had higher readmission rates, according to research presented at Crohn’s and Colitis Congress.
“NAFLD is highly prevalent in IBD patients,” Shaya Noorian, MD, of the University of California, Los Angeles, said in his presentation. “Currently,
Full Article: https://www.healio.com/news/gastroenterology/20210219/7-recent-reports-on-ibd